Form 8-K - Current report:
SEC Accession No. 0001104659-25-057524
Filing Date
2025-06-09
Accepted
2025-06-09 06:05:53
Documents
51
Period of Report
2025-06-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517442d1_8k.htm   iXBRL 8-K 25279
2 EXHIBIT 99.1 tm2517442d1_ex99-1.htm EX-99.1 64559
3 GRAPHIC tm2517442d1_ex99-1img001.jpg GRAPHIC 42546
4 GRAPHIC tm2517442d1_ex99-1img002.jpg GRAPHIC 330608
5 GRAPHIC tm2517442d1_ex99-1img003.jpg GRAPHIC 148846
6 GRAPHIC tm2517442d1_ex99-1img004.jpg GRAPHIC 149253
7 GRAPHIC tm2517442d1_ex99-1img005.jpg GRAPHIC 143377
8 GRAPHIC tm2517442d1_ex99-1img006.jpg GRAPHIC 131766
9 GRAPHIC tm2517442d1_ex99-1img007.jpg GRAPHIC 83940
10 GRAPHIC tm2517442d1_ex99-1img008.jpg GRAPHIC 34301
11 GRAPHIC tm2517442d1_ex99-1img009.jpg GRAPHIC 164307
12 GRAPHIC tm2517442d1_ex99-1img010.jpg GRAPHIC 147799
13 GRAPHIC tm2517442d1_ex99-1img011.jpg GRAPHIC 170925
14 GRAPHIC tm2517442d1_ex99-1img012.jpg GRAPHIC 146515
15 GRAPHIC tm2517442d1_ex99-1img013.jpg GRAPHIC 87253
16 GRAPHIC tm2517442d1_ex99-1img014.jpg GRAPHIC 180081
17 GRAPHIC tm2517442d1_ex99-1img015.jpg GRAPHIC 142033
18 GRAPHIC tm2517442d1_ex99-1img016.jpg GRAPHIC 202406
19 GRAPHIC tm2517442d1_ex99-1img017.jpg GRAPHIC 162472
20 GRAPHIC tm2517442d1_ex99-1img018.jpg GRAPHIC 124572
21 GRAPHIC tm2517442d1_ex99-1img019.jpg GRAPHIC 160975
22 GRAPHIC tm2517442d1_ex99-1img020.jpg GRAPHIC 178443
23 GRAPHIC tm2517442d1_ex99-1img021.jpg GRAPHIC 195576
24 GRAPHIC tm2517442d1_ex99-1img022.jpg GRAPHIC 164212
25 GRAPHIC tm2517442d1_ex99-1img023.jpg GRAPHIC 153869
26 GRAPHIC tm2517442d1_ex99-1img024.jpg GRAPHIC 144565
27 GRAPHIC tm2517442d1_ex99-1img025.jpg GRAPHIC 143987
28 GRAPHIC tm2517442d1_ex99-1img026.jpg GRAPHIC 111695
29 GRAPHIC tm2517442d1_ex99-1img027.jpg GRAPHIC 35340
30 GRAPHIC tm2517442d1_ex99-1img028.jpg GRAPHIC 139908
31 GRAPHIC tm2517442d1_ex99-1img029.jpg GRAPHIC 204243
32 GRAPHIC tm2517442d1_ex99-1img030.jpg GRAPHIC 188869
33 GRAPHIC tm2517442d1_ex99-1img031.jpg GRAPHIC 173158
34 GRAPHIC tm2517442d1_ex99-1img032.jpg GRAPHIC 145472
35 GRAPHIC tm2517442d1_ex99-1img033.jpg GRAPHIC 156287
36 GRAPHIC tm2517442d1_ex99-1img034.jpg GRAPHIC 191769
37 GRAPHIC tm2517442d1_ex99-1img035.jpg GRAPHIC 119798
38 GRAPHIC tm2517442d1_ex99-1img036.jpg GRAPHIC 32955
39 GRAPHIC tm2517442d1_ex99-1img037.jpg GRAPHIC 144559
40 GRAPHIC tm2517442d1_ex99-1img038.jpg GRAPHIC 148906
  Complete submission text file 0001104659-25-057524.txt   7837347

Data Files

Seq Description Document Type Size
41 XBRL TAXONOMY EXTENSION SCHEMA tvrd-20250606.xsd EX-101.SCH 3044
42 XBRL TAXONOMY EXTENSION LABEL LINKBASE tvrd-20250606_lab.xml EX-101.LAB 34239
43 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tvrd-20250606_pre.xml EX-101.PRE 22378
53 EXTRACTED XBRL INSTANCE DOCUMENT tm2517442d1_8k_htm.xml XML 3695
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 251032761
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)